Support for Patients and Communities Reauthorization Act
Where it stands
- Introduced7/11/23
- Passed HousePassed 12/12/23
- Senate
- President
- Law
Passed the House 386–37 on December 12, 2023 (Roll Call 715 →). Received in the Senate on December 13, 2023. No Senate action since.
Set your address to see how your representatives voted.
Roll calls on this bill
- Democratic196 Yea · 11 Nay · 6 Not voting
- Republican190 Yea · 26 Nay · 4 Not voting
- Independent / Other0 Yea · 0 Nay · 0 Not voting
Support for Patients and Communities Reauthorization Act
This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse.
This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs.
Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act.
Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.
What happens next
The Senate must pass the same text, then it goes to the President.
If it isn't enacted by Jan 3, 2025, it expires when the 118th Congress ends.
All actions (15)
- 7/11/23Introduced in House
- 7/11/23Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 7/19/23Committee Consideration and Mark-up Session Held.
- 7/19/23Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
- 9/28/23Committee Consideration and Mark-up Session Held
- 9/28/23Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 3.
- 12/11/23Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- 12/11/23Considered under suspension of the rules. (consideration: CR H6789-6797)
- 12/11/23DEBATE - The House proceeded with forty minutes of debate on H.R. 4531.
- 12/11/23At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- 12/12/23Considered as unfinished business. (consideration: CR H6836)
- 12/12/23Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
- 12/12/23On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
- 12/12/23Motion to reconsider laid on the table Agreed to without objection.
- 12/13/23Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.